Unlocking Precision in Diagnosis: The Rise of Molecular Point-of-Care Solutions

2024-04-01
PRNewswire
诊断试剂IPO
DUBLIN, April 1, 2024 /PRNewswire/ -- The "Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition" report has been added to
ResearchAndMarkets.com's offering.
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology.
The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition, is a valuable resource for understanding the size and growth potential of the molecular POC market from 2023-2028. mPOC has transitioned from a novel trend to a significant contributor to the market. Instruments from companies like Abbott, BioMerieux, Cepheid, and others play a substantial role in the IVD point-of-care market. Understanding these markets is crucial for assessing the opportunity in point-of-care testing and microbiology IVD.
The report provides market sizing, forecasting, trend mapping, and competitive analysis for POC tests using PCR or other molecular technology, offering fast turnaround times and usability in near-patient settings.
This report provides real-world analysis and modeling for relevant circumstances. Analysts offer insights into near-patient molecular testing using small instruments.
The data includes the following information on systems, competitor analysis, and the size and growth of the market:
What are the mPOC market opportunities beyond COVID-19?
What are the current systems on the market? Who's winning?
What's the size of the Molecular Point-of-Care Market: 2023-2028
Geographic Breakout of the Molecular Point-of-Care Market, 2023 (N. America, Europe, APAC, RoW)
Segment Breakout of Molecular Point-of-Care Market, 2023 (Respiratory vs. Other)
Near Patient Molecular IVD Market: 2023-2028
Near Patient Molecular Market Share by Vendor, 2023
Company Profiles
Competitive Analysis
Companies covered in this report, in profiles and/or product tables and market developments discussion include:
Aidian
binx health
bioMerieux
Credo Bioscience
Cue Health
Curetis
DiaSorin
Fluxergy
MicroGEM
Nanopath
Quidel
Key Topics Covered:
Chapter 1: Executive Summary
Where is Molecular Point-Of-Care in 2024?
Molecular Point-Of-Care Market Analysis
Market Observations
"Near-Patient" Molecular Systems Market
Current Trends
Molecular Point-Of-Care Diagnostics Defined
Usage of Molecular Point-Of-Care
Leading MPOC Platforms
Trends
Chapter 2: Molecular Point-Of-Care Market Development and Trends
COVID-19 and Molecular POC
CDC Initial Response, Long-Term Situation
COVID-19's Unique Challenge
Barda Directs Funding to MPOC
Regulatory Developments
Consortia, Funding, Prizes
Deals
Advantages and Disadvantages of Molecular Point-Of-Care
Justification: The Sensitivity/Specificity Argument
New Systems and Menu Expansion
Mesa Biotech Strep an Approval
Combination Tests Changing Market: Sars-Cov-2, Flu A, Flu B, and RSV
STI Continues to be a Growth Area
Deals, Investment in MPOC Systems
Roche Acquires Lumiradx for Up to $350M
EU Researchers Awarded €3M to Develop POC Molecular Tests
Scope Fluidics AST System Sees Investment
China as a POC Market
Common Tests and Analytes in POC Diagnostics
Component Technologies of Molecular Point-Of-Care Diagnostics
Microfluidics
qPCR
Microarrays
Isothermal Amplification
Test Automation
Primers and Probes
Detection
Next-Generation Sequencing
Real-Time PCR (qPCR)
Isothermal Amplification Methods
Line Probe Assays
Next-Generation Sequencing
Applications and Potential Applications for Molecular Point-Of-Care
Major Testing Applications for Molecular POC Diagnostics
Reclassification of RIDTs
Strep A
Respiratory Syncytial Virus (RSV)
Emerging Applications
Zika
Group B Streptococcus
Human Papillomavirus
Herpes Simplex Virus
Other Tropical and Neglected Diseases
Cancer
European Device Regulations
Chapter 3: Market Analysis
Molecular Point-Of-Care Market Analysis
"Near Patient Molecular" Market
Market Share Near Patient
Chapter 4: Company Profiles
Aidian
Cue Health
Curetis
Diasorin
Quidelortho
For more information about this report visit https://www.researchandmarkets.com/r/o5ztpv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。